Glycomine
Latest round
- Series C
Last raised
- Jul 2024
Total raised
- $176M
Investors
- 13
About Glycomine
Glycomine, Inc.Founded in 2014 and headquartered in San Carlos, California, Glycomine, Inc. specializes in therapies for rare genetic disorders.945 mn.Glycomine is dedicated to developing innovative replacement therapies for rare genetic diseases, particularly targeting PMM2-CDG (CDG Type 1a).S. and Europe. The product aims to deliver essential substrates to patients to restore disrupted protein function, thereby improving the quality of life for affected individuals.Glycomine's revenue model is primarily focused on the clinical development and potential commercialization of GLM101. The company has established strategic partnerships to advance its clinical trials, which may involve collaborations with healthcare organizations, research institutions, and pharmaceutical firms.In July 2024, Glycomine, Inc. Glycomine's strategic plans include launching new products in the near future, aligning with their goal to enhance treatment options for genetic diseases.
Who invested in Glycomine
13 investors across 4 rounds
See all investors in Glycomine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Glycomine
Who invested in Glycomine?
Glycomine has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glycomine raised?
Glycomine has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Glycomine last raise money?
Glycomine's most recent round on record is a Series C, in Jul 2024.
What does Glycomine do?
Glycomine is a biotechnology company.
Where is Glycomine headquartered?
Glycomine is headquartered in San Carlos, US.
Which VCs invest in companies like Glycomine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Glycomine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Glycomine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.